Clinical and genomic features of non-small cell lung cancer occurring in families

被引:1
作者
Miyabe, Shingo [1 ,2 ]
Ito, Shin [3 ]
Sato, Ikuro [4 ]
Abe, Jiro [1 ,5 ]
Tamai, Keiichi [3 ,5 ]
Mochizuki, Mai [3 ,5 ]
Fujimori, Haruna [5 ]
Yamaguchi, Kazunori
Shindo, Norihisa
Shima, Hiroshi [6 ]
Yamazaki, Tomoko [3 ]
Abue, Makoto [5 ]
Okada, Yoshinori [2 ]
Yasuda, Jun [3 ,7 ,8 ]
机构
[1] Miyagi Canc Ctr Hosp, Div Thorac Surg, Natori, Japan
[2] Tohoku Univ, Inst Dev Aging & Canc, Dept Thorac Surg, Sendai, Japan
[3] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, Natori, Japan
[4] Miyagi Canc Ctr Hosp, Div Pathol, Natori, Japan
[5] Miyagi Canc Ctr Res Inst, Div Canc Stem Cell, Natori, Japan
[6] Miyagi Canc Ctr Res Inst, Div Canc Chemotherapy, Natori, Japan
[7] Miyagi Canc Ctr Res Inst, Div Mol & Cellular Oncol, 47-1 Nodayama, Natori, Miyagi 9811293, Japan
[8] Saitama Med Univ, Dept Head & Neck Oncol, Int Med Ctr, Saitama, Japan
关键词
DHODH; exome; mutational signature; non-small cell lung cancer; tumor suppressor gene; GENETIC-VARIANTS; RISK; SUSCEPTIBILITY;
D O I
10.1111/1759-7714.14825
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Exposure to environmental carcinogens, such as through smoking, is a major factor in the carcinogenesis of non-small cell lung cancer (NSCLC). However, genetic factors may also contribute.Methods To identify candidate tumor suppressor genes for NSCLC, we included 23 patients (10 related pairs and 3 individuals) with NSCLC who had other NSCLC-affected first-degree relatives in a local hospital. Exome analyses for both germline and somatic (NSCLC specimens) DNA were performed for 17 cases. Germline exome data of these 17 cases revealed that most of the short variants were identical to the variants in 14KJPN (a Japanese reference genome panel of more than 14 000 individuals) and only a nonsynonymous variant in the DHODH gene, p.A347T, was shared between a pair of NSCLC patients in the same family. This variant is a known pathogenic variant of the gene for Miller syndrome.Results Somatic genetic alterations in the exome data of our samples showed frequent mutations in the EGFR and TP53 genes. Principal component analysis of the patterns of 96 types of single nucleotide variants (SNVs) suggested the existence of unique mechanisms inducing somatic SNVs in each family. Delineation of mutational signatures of the somatic SNVs with deconstructSigs for the pair of germline pathogenic DHODH variant-positive cases showed that the mutational signatures of these cases included SBS3 (homologous recombination repair defect), SBS6, 15 (DNA mismatch repair), and SBS7 (ultraviolet exposure), suggesting that disordered pyrimidine production causes increased errors in DNA repair systems in these cases.Conclusion Our results suggest the importance of the detailed collection of data on environmental exposure along with genetic information on NSCLC patients to identify the unique combinations that cause lung tumorigenesis in a particular family.
引用
收藏
页码:940 / 952
页数:13
相关论文
共 50 条
  • [31] Clinical applications of circulating biomarkers in non-small cell lung cancer
    Oh, Hyun-Ji
    Imam-Aliagan, Abdulhamid B.
    Kim, Yeo-Bin
    Kim, Hyun-Jin
    Izaguirre, Issac A.
    Sung, Chang K.
    Yim, Hyungshin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12
  • [32] Wedge Resection for Clinical-nO Non-Small Cell Lung Cancer
    Tsunezuka, Hiroaki
    Kato, Daishiro
    Okada, Satoru
    Furuya, Tatsuo
    Shimada, Junichi
    Inoue, Masayoshi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1394 - S1394
  • [33] Clinical use of crizotinib for the treatment of non-small cell lung cancer
    Roberts, Patrick J.
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 91 - 101
  • [34] Immune-Related Genomic Features in Non-Small-Cell Lung Cancer
    Wang, Z.
    Lu, B.
    Xu, T.
    Wei, C.
    Ma, L.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1208 - S1208
  • [35] Genomic Aberrations Associated with Erlotinib Resistance in Non-small Cell Lung Cancer Cells
    Serizawa, Masakuni
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Koh, Yasuhiro
    ANTICANCER RESEARCH, 2013, 33 (12) : 5223 - 5233
  • [36] Characteristics of Genomic Alterations in Pericardial Effusion of Advanced Non-small Cell Lung Cancer
    He, Jiaxue
    Hu, Xintong
    Chen, Liguo
    Liu, Qiaoliang
    Jiang, Yanfang
    FRONTIERS IN GENETICS, 2022, 13
  • [37] Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer
    Wang, Zizong
    Han, Yushuai
    Tao, Houquan
    Xu, Mengxiang
    Liu, Zhengchuang
    Zhu, Jianhua
    Li, Wei
    Ma, Jie
    Liu, Zhifang
    Wang, Weiran
    Ma, Tonghui
    MOLECULAR ONCOLOGY, 2023, 17 (05) : 765 - 778
  • [38] Targeting HER2 genomic alterations in non-small cell lung cancer
    Zeng, Jie
    Ma, Weijie
    Young, Richard Benjamin
    Li, Tianhong
    JOURNAL OF THE NATIONAL CANCER CENTER, 2021, 1 (02): : 58 - 73
  • [39] Genomic medicine in non-small cell lung cancer: Paving the path to personalized care
    Sriram, Krishna Bajee
    Larsen, Jill Everland
    Yang, Ian Anthony
    Bowman, Rayleen Veronica
    Fong, Kwun Meng
    RESPIROLOGY, 2011, 16 (02) : 257 - 263
  • [40] Angiogenesis and non-small cell lung cancer
    Cox, G
    Jones, JL
    Walker, RA
    Steward, WP
    O'Byrne, KJ
    LUNG CANCER, 2000, 27 (02) : 81 - 100